Cash Flow Statement

Currency: USD

	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023
Operating Cash Flow
Net Income	(10)	(8)	(12)	(15)	(16)	(19)	(20)	(22)	(25)	(25)	(24)	(20)	(19)	(15)	(14)
Depreciation & Amortization	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Other Non-Cash Items	3	2	6	7	6	7	4	3	3	3	2	0	1	(2)	(2)
Cash Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Working Capital	3	2	(0)	(2)	(3)	(4)	0	1	2	1	2	2	2	4	3
Cash from Operating Activities	(4) N/A	(4) +3%	(6) -56%	(10) -68%	(12) -24%	(15) -29%	(16) -3%	(18) -14%	(19) -5%	(21) -9%	(20) +5%	(17) +13%	(15) +11%	(12) +20%	(12) +2%
Investing Cash Flow
Capital Expenditures	(0)	(0)	(0)	(0)	(2)	(2)	(2)	(2)	(1)	(1)	(1)	(1)	(1)	(1)	(1)
Other Items	0	0	0	0	(0)	(0)	(0)	0	0	0	0	(0)	(0)	(0)	(0)
Cash from Investing Activities	0 N/A	0 +7%	(0) N/A	(0) -217%	(2) -400%	(2) -22%	(3) -13%	(2) +5%	(1) +42%	(1) +24%	(1) +16%	(1) -18%	(1) +24%	(1) -7%	(1) +4%
Financing Cash Flow
Net Issuance of Common Stock	0	2	23	0	50	47	26	0	(1)	0	0	8	8	8	12
Net Issuance of Debt	4	2	1	1	(0)	(0)	(0)	0	0	0	0	0	0	0	0
Other	0	(0)	(0)	0	(2)	(2)	(2)	0	0	0	0	(1)	(1)	(1)	(1)
Cash from Financing Activities	4 N/A	4 +3%	24 +501%	24 0%	47 +102%	45 -6%	24 -46%	24 +0%	(1) N/A	0 N/A	0 N/A	7 N/A	7 N/A	7 N/A	11 +48%
Change in Cash
Net Change in Cash	0 N/A	0 +159%	18 +3 932%	14 -23%	34 +149%	27 -20%	6 -78%	4 -35%	(22) N/A	(22) -1%	(21) +6%	(11) +47%	(9) +19%	(6) +34%	(2) +67%
Free Cash Flow
Free Cash Flow	(4) N/A	(4) +4%	(6) -55%	(10) -71%	(13) -36%	(17) -29%	(18) -5%	(20) -11%	(20) -1%	(22) -7%	(21) +6%	(18) +12%	(16) +11%	(13) +19%	(13) +2%

Vivos Therapeutics Inc
NASDAQ:VVOS